These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
158 related items for PubMed ID: 11949504
1. [Drugs in Europe]. Bouzy C, Abadie E. Rev Prat; 2002 Mar 01; 52(5):510-4. PubMed ID: 11949504 [Abstract] [Full Text] [Related]
2. [Europe and medicines: role of the EMEA]. Sauer F. Ann Pharm Fr; 2000 Jul 01; 58(4):278-85. PubMed ID: 10915977 [Abstract] [Full Text] [Related]
3. [New drugs and European procedures of approval. The European Agency for the Evaluation of Medicinal Products' role]. Ainsworth MA. Ugeskr Laeger; 2003 Apr 14; 165(16):1648-9. PubMed ID: 12756819 [Abstract] [Full Text] [Related]
4. [European Agency for the Evaluation of Medicinal Products: five years experience]. Sauer F. Bull Mem Acad R Med Belg; 2000 Apr 14; 155(5-6):254-8; discussion 259-62. PubMed ID: 11304960 [Abstract] [Full Text] [Related]
5. [National and European drug approval procedures]. Mohrbutter KP. Z Arztl Fortbild Qualitatssich; 1997 Nov 14; 91(7):593-6. PubMed ID: 9527447 [Abstract] [Full Text] [Related]
6. Medicines for children licensed by the European Agency for the Evaluation of Medicinal Products. Ceci A, Felisi M, Catapano M, Baiardi P, Cipollina L, Ravera S, Bagnulo S, Reggio S, Rondini G. Eur J Clin Pharmacol; 2002 Nov 14; 58(8):495-500. PubMed ID: 12451425 [Abstract] [Full Text] [Related]
7. [Registration of new medicinal products in Europe]. Singer E. Onkologie; 2008 Nov 14; 31 Suppl 2():64-6. PubMed ID: 18487872 [Abstract] [Full Text] [Related]
8. [Approval of drugs by national and European agencies--from the viewpoint of drug approval committee A]. Henschler D. Z Arztl Fortbild Qualitatssich; 1997 Nov 14; 91(7):600-3. PubMed ID: 9527449 [Abstract] [Full Text] [Related]
9. [Drug evaluation: new requirements and perspectives]. Addis A, Rocchi F. Recenti Prog Med; 2006 Nov 14; 97(11):618-25. PubMed ID: 17252718 [Abstract] [Full Text] [Related]
10. The regulatory system in europe with special emphasis on allergen products. Lorenz AR, Luttkopf D, Seitz R, Vieths S. Int Arch Allergy Immunol; 2008 Nov 14; 147(4):263-75. PubMed ID: 18648190 [Abstract] [Full Text] [Related]
11. [Approval of drugs by national and European agencies--sequelae for the pharmaceutical industry]. Zierenberg O. Z Arztl Fortbild Qualitatssich; 1997 Nov 14; 91(7):596-600. PubMed ID: 9527448 [Abstract] [Full Text] [Related]
12. The future European system for the free circulation of veterinary vaccines in Europe. Hankin R. Dev Biol Stand; 1992 Nov 14; 79():3-9. PubMed ID: 1286761 [Abstract] [Full Text] [Related]
13. Comparators (medicinal and non medicinal) for marketing authorization, for public health, for payers and at the European level. Berdaï D, Hotton JM, Lechat P, participates of Round Table n° 1 Giens XXV. Therapie; 2010 Nov 14; 65(4):329-34. PubMed ID: 20854755 [Abstract] [Full Text] [Related]
15. The reorganisation of European pharmacovigilance. Part 2. From spontaneous reports to agency reviews and decisions. Prescrire Int; 2015 Feb 14; 24(157):50-4. PubMed ID: 25802924 [Abstract] [Full Text] [Related]
17. Legal requirements for the quality of herbal substances and herbal preparations for the manufacturing of herbal medicinal products in the European union. Vlietinck A, Pieters L, Apers S. Planta Med; 2009 Jun 14; 75(7):683-8. PubMed ID: 19204891 [Abstract] [Full Text] [Related]